Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.66 |
| ▸ | CA9 | Q16790 | 4/20 | 0.66 |
| ▸ | CA4 | P22748 | 3/20 | 0.66 |
| ▸ | CA1 | P00915 | 1/20 | 0.66 |
| ▸ | MAOB | P27338 | 12/20 | 0.62 |
| ▸ | MAOA | P21397 | 9/20 | 0.62 |
| ▸ | GLA | P06280 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11502238 | 0.83 | MAOB (0.66) | CA12CA9CA4CA1MAOB | |
| SCHEMBL8756380 | 0.81 | GLA (0.64) | CA12CA9CA4CA1MAOB | |
| SCHEMBL11502161 | 0.80 | MAOB (0.76) | CA12CA9CA4CA1MAOB | |
| SCHEMBL30127638 | 0.80 | CA12 (1.00) | CA12CA9CA4CA1MAOB | |
| SCHEMBL8512573 | 0.80 | CA12 (1.00) | CA12CA9CA4CA1MAOB | |
| SCHEMBL18474355 | 0.79 | CA9 (0.65) | CA12CA9CA4CA1MAOB | |
| SCHEMBL4041859 | 0.76 | CA12 (0.64) | CA12CA9CA4CA1MAOB | |
| SCHEMBL20095261 | 0.76 | MAOB (0.49) | CA12CA9CA4CA1MAOB | |
| SCHEMBL5904507 | 0.75 | CA12 (1.00) | CA12CA9CA4CA1MAOB | |
| SCHEMBL11502126 | 0.75 | MAOB (0.79) | CA12CA9CA4CA1MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11129909-B2 | Conjugate and block copolymer containing fluorescent chromophore and preparation method therefor and use thereof | UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA (CN) | 2021-09-28 | — | — | US | disclosed |
| US-20200155707-A1 | CONJUGATE AND BLOCK COPOLYMER CONTAINING FLUORESCENT CHROMOPHORE AND PREPARATION METHOD THEREFOR AND USE THEREOF | UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA (CN) | 2020-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11129909-B2 | Conjugate and block copolymer containing fluorescent chromophore and preparation method therefor and use thereof | WEE1, FAR1, FURIN | CA12 252/4885CA9 2428/4885CA4 909/4885 |
| US-20200155707-A1 | CONJUGATE AND BLOCK COPOLYMER CONTAINING FLUORESCENT CHROMOPHORE AND PREPARATION METHOD THEREFOR AND USE THEREOF | WEE1, FAR1, FURIN | CA12 252/4885CA9 2428/4885CA4 909/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.